India’s Laurus Labs is aiming to supply antiretrovirals through South Africa’s public tender system after agreeing a deal to buy Aspen Pharmacare’s Phekolong Pharmaceuticals subsidiary.

By weakening ways to challenge drug patent thickets, proposed legislation to reform US patent law would extend brand monopolies and increase spending on medicines, the Association for Accessible Medicines is warning.

Fixed-dose polypills containing commonly available generic cardiovascular agents could cut risks in low-income populations within the US, a randomized clinical trial suggests.

Launching eight heparin vial presentations in the US is evidence of how injectables specialist Meitheal Pharmaceuticals intends to leverage the vertically-integrated production capacity of its Chinese parent group NKF.

Interchangeability should be seen as a scientific concept rather than a therapeutic choice of biosimilar or reference biologic, Spanish physicians argue in a journal article.